Cell based therapy for the treatment of neuropsychiatric disorders

Worldwide, neuropsychiatric illnesses have a significant negative impact on the economy, health care system, and wellbeing of affected patients and their dependents (1). Neuropsychiatric disorders, such as major depressive disorder (MDD), schizophrenia (SZ), or bipolar disorder (BD), is thought to affect at least one in four members families.